07/03/2006 - 21:00

C3 reports $5.6m first-half loss

07/03/2006 - 21:00

Bookmark

Save articles for future reference.

CLINICAL Cell Culture Ltd (C3) reported an operating loss of $5.6 million, which was up 9 per cent on the previous result, as it continues its investment in growing its distribution capabilities and supporting sales infrastructure.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options